胸腹常温区域灌注供肺移植的早期至中期结局:器官获取与移植网络分析
基于UNOS/OPTN数据库2020年至2025年中期对照循环死亡后捐献肺移植的回顾性分析,比较胸腹常温区域灌注(TA-NRP)与标准快速获取的供肺移植结局。TA-NRP组受者48小时以上通气需求和住院时间在未调整时较低,调整供者年龄、性别、地区和年份后差异减弱,但72小时ECMO使用几率更低(aOR 0.63,p=0.03);1年和3年生存率相当。
要点
- TA-NRP供肺移植后1年和3年生存率与标准快速获取相当。
- 调整混杂因素后,TA-NRP组72小时ECMO使用几率显著更低(aOR 0.63,p=0.03)。
- 同期心脏获取或体外肺灌注的使用未影响肺移植结局。
核心结论
- 尽管存在对TA-NRP后结局较差的担忧,肺移植的短期和中期结局支持该获取技术的安全性。
研究设计与样本
- 利用UNOS/OPTN数据库对2020年至2025年中期对照循环死亡后捐献的肺移植进行回顾性分析。
- 比较接受TA-NRP获取供肺的受者与接受标准快速获取(SRR)供肺的受者。
- 共识别1333例SRR和253例TA-NRP供者,以及1364例SRR和261例TA-NRP肺移植受者。
主要发现
- TA-NRP供者较SRR供者更年轻(37.9岁 vs 41.0岁,p<0.001),男性比例更高(67.2% vs 56.7%,p=0.005)。
- TA-NRP受者需要通气>48小时的比例更低(48% vs 56%,p=0.02),住院时间更短(21天 vs 24天,p=0.02)。
- 调整供者年龄、性别、地理区域和年份后,上述差异均减弱,但TA-NRP受者72小时ECMO使用几率更低(aOR 0.63,p=0.03)。
- TA-NRP与SRR受者的1年和3年生存率相当。
- 同期心脏获取或体外肺灌注的使用均未影响肺移植结局。
临床怎么用
- TA-NRP可用于对照循环死亡后捐献的肺获取,短期和中期结局支持其安全性。
- 临床决策时需考虑供者年龄、性别等因素对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The use of thoracoabdominal normothermic regional perfusion (TA-NRP) for organ procurement has rapidly increased in recent years. Although excellent posttransplant outcomes have been achieved using TA-NRP in cardiac and abdominal transplantation, there are concerns that peri-procedural changes during lung procurement may lead to inferior preservation and poorer lung transplant outcomes. To guide clinical practice, we evaluated early and mid-term lung transplant outcomes after procurement using TA-NRP. METHODS: Using the UNOS/OPTN database, we conducted a retrospective analysis of lung transplants performed after controlled donation after circulatory death from 2020 through mid-2025. Recipients with lungs procured using TA-NRP were compared with recipients of lungs procured with standard rapid recovery (SRR). RESULTS: We identified 1333 SRR and 253 TA-NRP lung donors and 1364 SRR and 261 TA-NRP lung transplant recipients. TA-NRP donors were younger (37.9 vs 41.0 years, p<0.001) and more often male (67.2% vs 56.7%, p=0.005) than the SRR donors. TA-NRP recipients required ventilation >48 hours less often (48% vs 56%, p=0.02) and had shorter hospital stays (21 vs 24 days, p=0.02), but adjustment for donor age, sex, geographic region, and year attenuated both differences while revealing lower odds of ECMO use at 72 hours in TA-NRP recipients (aOR 0.63, p=0.03). One- and 3-year survival were comparable between TA-NRP and SRR recipients, and neither concurrent heart procurement nor use of ex vivo lung perfusion affected lung allograft outcomes. CONCLUSION: Despite concerns of poorer outcomes after TA-NRP, short- and mid-term outcomes of lung transplant support the safety of this procurement technique.
引用
- O'Neill JW, Gregorio PHP, Hassaballa AS, et al. Early-to-midterm outcomes of lung transplantation following procurement with thoracoabdominal normothermic regional perfusion: An organ procurement and transplantation network analysis. J Heart Lung Transplant. 2026. PMID: 42731647. doi:10.1016/j.healun.2026.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。